BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21617089)

  • 1. Nurse-coordinated care in CKD: time for translation into practice?
    Smith DH; Thorp ML
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1229-31. PubMed ID: 21617089
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.
    Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ; Goeree R
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1248-57. PubMed ID: 21617091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.
    Barrett BJ; Garg AX; Goeree R; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Ayers D; Parfrey PS
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1241-7. PubMed ID: 21617090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria and cardiovascular risk: time for a new direction?
    Charytan DM
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1235-7. PubMed ID: 21597027
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive medical management of peripheral arterial disease.
    Gandhi S; Weinberg I; Margey R; Jaff MR
    Prog Cardiovasc Dis; 2011; 54(1):2-13. PubMed ID: 21722781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease.
    van Zuilen AD; Bots ML; Dulger A; van der Tweel I; van Buren M; Ten Dam MA; Kaasjager KA; Ligtenberg G; Sijpkens YW; Sluiter HE; van de Ven PJ; Vervoort G; Vleming LJ; Blankestijn PJ; Wetzels JF
    Kidney Int; 2012 Sep; 82(6):710-7. PubMed ID: 22739979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positioning of CKD in risk stratification].
    Ito S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):461-4. PubMed ID: 19601554
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for chronic kidney disease: which strategy?
    Hallan SI; Stevens P
    J Nephrol; 2010; 23(2):147-55. PubMed ID: 20155721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B; Henriksson M; Lundin F; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward?
    Wali RK
    J Am Coll Cardiol; 2010 Sep; 56(12):966-8. PubMed ID: 20828649
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B; Barreto-Filho JA
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501
    [No Abstract]   [Full Text] [Related]  

  • 14. Stenting for renal artery stenosis: effects of contested data on opposing management strategies.
    Topaz O
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):11-3. PubMed ID: 20020428
    [No Abstract]   [Full Text] [Related]  

  • 15. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
    Reiner Z
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
    [No Abstract]   [Full Text] [Related]  

  • 16. An ounce of prevention.
    Fuster V
    Nat Rev Cardiol; 2009 Sep; 6(9):553-4. PubMed ID: 19696772
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance measures in million hearts: 2 partners' perspective.
    Drozda JP; Holmes DP
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):587-8. PubMed ID: 22811502
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The elderly with advanced chronic kidney disease.
    Abutaleb N
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):156-8; author reply 158-9. PubMed ID: 21196638
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advances in detection, evaluation and management of chronic kidney disease].
    Indridason OS; Thorsteinsdóttir I; Pálsson R
    Laeknabladid; 2007 Mar; 93(3):201-7. PubMed ID: 17341799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.